3778-25-4

Basic information

• Product Name: 7''-O-Methylsciadopitysin
• Synonyms: 7''-O-Methylsciadopitysin;7,4',7'',4'''-Tetra-O-methylamentoflavone;Amentoflavone 4',4''',7,7''-tetramethyl ether
• CAS NO: 3778-25-4
• Molecular Formula: C₃₄H₂₆O₁₀
• Molecular Weight: 594.56424
• Mol File: 3778-25-4.mol
• Article Data: 4

Chemical Properties

• Melting Point: 292-294℃
• Appearance: /
• CAS DataBase Reference: 7''-O-Methylsciadopitysin(CAS DataBase Reference)
• NIST Chemistry Reference: 7''-O-Methylsciadopitysin(3778-25-4)
• EPA Substance Registry System: 7''-O-Methylsciadopitysin(3778-25-4)

Safety Data

• Hazardous Substances Data: 3778-25-4(Hazardous Substances Data)

Usage

General Description

7''-O-Methylsciadopitysin is a natural chemical compound found in certain plants, including fir trees and magnolias. It belongs to the flavonoid group of compounds and is known for its antioxidant properties. 7''-O-Methylsciadopitysin has been studied for its potential therapeutic effects, including its ability to inhibit lipid peroxidation and reduce oxidative stress in cells. It has also been investigated for its potential use as a natural remedy for various health conditions, including cardiovascular disorders and cancer. The compound has shown promise in preclinical studies, but further research is needed to fully understand its pharmacological properties and potential applications in medicine.

Upstream product

• 186581-53-3 diazomethane 
• 22136-74-9 podocarpusflavone A 
• 481-45-8 amentoflavone 4',7'',4'''-trimethyl ether 
• 3778-26-5 Amentoflavon 
• 548-19-6 isoginkgetin 
• 74-88-4 methyl iodide 
• 1617-53-4 amentoflavone 
• 77-78-1 dimethyl sulfate 

Downstream Products

• 22783-09-1 5,5'-diacetoxy-7,7'-dimethoxy-2'-(4-methoxy-phenyl)-2,8'-(4-methoxy-m-phenylene)-bis-chromen-4-one 

Relevant articles and documents

COMPOUNDS, COMPOSITION AND USES THEREOF FOR TREATING CANCER

The present invention relates to the fields of medicine and cancer treatment. The invention more specifically relates to new compounds which are typically for use as a medicament. In particular, the invention relates to the use of these new compounds for increasing the presentation, typically the production and presentation, of Pioneer Translation Products (PTPs)-derived antigens by cancer cells in a subject, and inducing or stimulating an immune response in the subject. The present disclosure also relates to uses of such compounds, in particular to prepare a pharmaceutical composition and/or to allow or improve the efficiency of a cancer therapy in a subject in need thereof. The invention also discloses methods for preventing or treating cancer, cancer metastasis and/or cancer recurrence in a subject. The present invention in addition provides kits suitable for preparing a composition according to the present invention and/or for implementing the herein described methods.

TERPENOID AND BIFLAVONOID CONSTITUENTS OF CALOPHYLLUM CALABA AND GARCINIA SPICATA FROM SRI LANKA

A new bark acid, isochapelieric acid (cis-chapelieric acid), chapelieric acid, friedelin, friedelan-3β-ol, canophyllal, canophyllol, friedelan-3β,28-diol, canophyllic acid and amentoflavone have been isolated and characterized from leaf extractives of Cal